Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

32.75 UNCHANGED
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 32.66 (100)
Ask (Size) 32.74 (3,600)
Prev. Close 32.75
Today's Range 32.75 - 32.75
52wk Range 22.28 - 48.92
Shares Outstanding 391,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery
As of December 24, 2025, Moderna, Inc. (Nasdaq: MRNA) finds itself at a pivotal crossroads in its corporate evolution. Once the definitive success story of the pandemic era, the Cambridge-based... 
Via PredictStreet
Topics Initial Public Offering
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill

Performance

YTD
-22.0%
-22.0%
1 Month
+35.6%
+35.6%
3 Month
+26.5%
+26.5%
6 Month
+21.9%
+21.9%
1 Year
-18.7%
-18.7%

More News

Read More
News headline image
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Monday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Top S&P500 movers in Monday's session ↗
Via Chartmill
News headline image
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
News headline image
Why Is Moderna (MRNA) Stock Rocketing Higher Today
Via StockStory
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Down 80%, Should You Buy the Dip on Moderna? ↗
Via The Motley Fool
News headline image
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
News headline image
Why Moderna (MRNA) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence
News headline image
CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate
Via ACCESS Newswire
News headline image
Moderna (MRNA) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence
News headline image
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
News headline image
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
Via ACCESS Newswire
News headline image
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
Via MarketMinute
Topics Intellectual Property
News headline image
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)
Via ACCESS Newswire
News headline image
3 Cash-Burning Stocks We Steer Clear Of
Via StockStory
News headline image
Moderna (MRNA) Q4 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Moderna (MRNA) Q3 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Moderna (MRNA) Q1 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Moderna (MRNA) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Moderna (MRNA) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 32.75
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 12/24/25 01:00 PM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 12.81B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.